50 participants
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-02
- Start Date:
- 2026-04-28
- Completion:
- 2033-02-23
Conditions
- Chronic Myelogenous Leukemia
- Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive
Interventions
- DRUG
No Results Yet